Newsroom

LONDON--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Sand Grove Capital Management LLP (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must...

STAMFORD, Conn.--(BUSINESS WIRE)--ISG has launched a study of service providers helping firms adopt more data-centric, AI-enabled workforce management through the UKG Pro ecosystem....

LOS ANGELES und SEOUL, Südkorea--(BUSINESS WIRE)--Heute ist das offizielle Release von „Something Special“, der mit Spannung erwarteten Cross-Market-Kooperation zwischen dem internationalen Star Ahn Hyo-seop und dem mehrfach mit Platin ausgezeichneten Musiker Khalid, die ab sofort über FANDOM auf allen großen Streaming-Plattformen erhältlich ist. Streamen Sie die Single HIER. Musicow wird im Juni zudem ein offizielles Musikvideo veröffentlichen, das die einzigartige Chemie zwischen Ahn Hyo-seop...

LOS ANGELES et SÉOUL, Corée du Sud--(BUSINESS WIRE)--Aujourd’hui marque la sortie officielle de « Something Special », la collaboration intercontinentale très attendue entre la star internationale Ahn Hyo-seop et l’artiste multi-platine Khalid, désormais disponible via FANDOM sur toutes les principales plateformes de streaming. Écoutez le single ICI. Musicow sortira également un clip officiel en juin, mettant en avant la complicité unique entre Ahn Hyo-seop et Khalid tout en donnant vie à la co...

Los Angeles e Seul, Coreia do Sul--(BUSINESS WIRE)--Hoje foi marcado o lançamento oficial de “Something Special”, a tão aguardada colaboração internacional entre o astro internacional Ahn Hyo-seop e o artista multiplatinado Khalid, disponível agora via FANDOM em todas as principais plataformas de streaming. Ouça o single AQUI. A Musicow também lançará um videoclipe oficial em junho, destacando a química única entre Ahn Hyo-seop e Khalid e dando vida à colaboração intercultural da música nas tel...

LOS ANGELES e SEUL, Corea del Sud--(BUSINESS WIRE)--Oggi segna il rilascio ufficiale di “Something Special”, l'attesissima collaborazione interculturale della stella internazionale Ahn Hyo-seop e dell'artista vincitore di vari dischi di platino Khalid, disponibile ora attraverso FANDOM su tutte le principali piattaforme di streaming. Per ascoltare il brano fare clic QUI. Musicow rilascerà anche un video musicale in giugno, evidenziando la chimica unica tra Ahn Hyo-seop e Khalid, dando vita sull...

LONDON--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser:   Sand Grove Capital Management LLP (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries mu...

LOS ANGELES & SEOUL, Zuid-Korea--(BUSINESS WIRE)--Vandaag is de officiële releasedatum van "Something Special", de langverwachte samenwerking tussen internationale ster Ahn Hyo-seop en multi-platina artiest Khalid. De single is nu beschikbaar via FANDOM op alle grote streamingplatforms. Stream de single HIER. Musicow brengt in juni ook een officiële videoclip uit, waarin de unieke chemie tussen Ahn Hyo-seop en Khalid tot uiting komt. Met het lied brengen zij hun interculturele samenwerking tot...

SANTA CLARA, Calif.--(BUSINESS WIRE)--ZFLOW AI is building a neutral optimization and control layer for AI infrastructure....

TOKYO--(BUSINESS WIRE)--Daiichi Sankyo (TSE: 4568) and AstraZeneca’s (LSE/STO/NYSE: AZN) Datroway® (datopotamab deruxtecan-dlnk) has been approved in the U.S. for the treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. Datroway is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo and being jointly developed and commercialized by Daiichi Sank...